Document is current
Any future updates will be listed below
-
Authors
Nogi, Shohei
Kagawa, Shunsuke https://orcid.org/0000-0002-3610-8211
Taniguchi, Atsuki
Yagi, Tomohiko
Kanaya, Nobuhiko
Kakiuchi, Yoshihiko
Yasui, Kazuya
Fuji, Tomokazu
Kono, Yoshiyasu
Kikuchi, Satoru
Takagi, Kosei
Kuroda, Shinji https://orcid.org/0000-0002-4484-1253
Teraishi, Fuminori
Tazawa, Hiroshi https://orcid.org/0000-0003-4658-1050
Fujiwara, Toshiyoshi
-
Funding
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (JP220K8873)
- License Information
-
More Information
Article History
Received: 8 April 2025
Revised: 3 August 2025
Accepted: 2 September 2025
First Online: 25 September 2025
Competing interests
: The authors declare no competing interests.
: This study using clinical samples from patients with pancreatic cancer was approved by the Institutional Review Board of Okayama University (No. 2406-025) and was conducted in accordance with the Declaration of Helsinki. The requirement for written informed consent was waived owing to the retrospective nature of the study, and information regarding the study was disclosed to patients with the opportunity to opt out. All animal experimental protocols were approved by the Institutional Animal Care and Use Committee of Okayama University. All methods were performed in accordance with the relevant guidelines and regulations.
: During the preparation of this work the authors used OpenAI’s ChatGPT for language refinement and assistance in editing the manuscript. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the published article.
